Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer

Pathology and Oncology Research

Volumn 19, Issue 4, 2013, Pages 749-753

  Zhu, Mingchen ^a   Xu, Yijun ^b   Mao, Xuelian ^a   Gao, Yanfang ^a   Shao, Lijia ^a   Yan, Feng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal caner; Immunohistochemistry; MACC1; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ESOPHAGUS CANCER; FEMALE; GENE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MACC1 GENE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL;

AGED; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; REGRESSION ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84885178255     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9638-9     Document Type: Article

References (28)

1. Pisani P, Parkin DM, Bray F et al (1999) Erratum: estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18-29 (1999). Int J Cancer 83:870-873
2. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349:2241-2252
3. Blanchard P, Quero L, Hennequin C (2009) Prognostic and predictive factors of oesophageal carcinoma. Bull Cancer 96:379-389
4. Lin YC, Wu MY, Li DR et al (2004) Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World J Gastroenterol 10:3235-3239
5. Michaylira CZ, Wong GS, Miller CG et al (2010) Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer. Cancer Res 70:5281-5292
6. Kadowaki T, Shiozaki H, Inoue M et al (1994) E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res 54:291-296
7. Chen M, Cai E, Huang J et al (2012) Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 21:1126-1134
8. Stoker M, Gherardi E, Perryman M et al (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327:239-242
9. Lesko E, Majka M (2008) The biological role of HGF-MET axis in tumor growth and development of metastasis. Front Biosci 13:1271-1280
10. Horiguchi N, Takayama H, Toyoda M et al (2002) Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 21:1791-1799
11. Zhang YW, Vande Woude GF (2003) HGF/SF-met signaling in the control of branching morphogenesis and invasion. J Cell Biochem 88:408-417
12. Vande Woude GF, Jeffers M, Cortner J et al (1997) Met-HGF/SF: tumorigenesis, invasion and metastasis. CIBA Found Symp 212:119-130, discussion 130-2, 148-154
13. Gumustekin M, Kargi A, Bulut G et al (2011) HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer. Pathol Oncol Res 18:209-218
14. Toschi L, Janne PA (2008) Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin Cancer Res 14:5941-5946
15. Birchmeier C, Birchmeier W, Gherardi E et al (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915-925
16. Okano J, Shiota G, Matsumoto K et al (2003) Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem Biophys Res Commun 309:298-304
17. Ye M, Hu D, Tu L et al (2008) Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Investig Ophthalmol Vis Sci 49:497-504
18. Stein U, Walther W, Arlt F et al (2009) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15:59-67
19. Shirahata A, Sakata M, Kitamura Y et al (2010) MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res 30:3441-3444
20. Chundong G, Uramoto H, Onitsuka T et al (2011) Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res 31:1141-1145
21. Shirahata A, Fan W, Sakuraba K et al (2011) MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 31:777-780
22. Lang AH, Geller-Rhomberg S, Winder T et al (2012) A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients. BMC Cancer 12:20
23. Qiu J, Huang P, Liu Q et al (2011) Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 9:166
24. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895-904
25. Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127:679-695
26. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12:89-96
27. Liang P, Pardee AB (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971
28. Peschard P, Park M (2007) From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 26:1276-1285